146 related articles for article (PubMed ID: 8296794)
1. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation.
Wada H; Nakase T; Nakaya R; Minamikawa K; Wakita Y; Kaneko T; Ohiwa M; Deguchi K; Shirakawa S
Am J Hematol; 1994 Mar; 45(3):232-6. PubMed ID: 8296794
[TBL] [Abstract][Full Text] [Related]
2. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
3. Role of tissue factor in disseminated intravascular coagulation.
Asakura H; Kamikubo Y; Goto A; Shiratori Y; Yamazaki M; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E
Thromb Res; 1995 Nov; 80(3):217-24. PubMed ID: 8578548
[TBL] [Abstract][Full Text] [Related]
4. Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.
Takahashi H; Sato N; Shibata A
Thromb Res; 1995 Nov; 80(4):339-48. PubMed ID: 8585047
[TBL] [Abstract][Full Text] [Related]
5. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Satoh N; Wada K; Takakuwa E; Seki Y; Shibata A
Am J Hematol; 1994 Aug; 46(4):333-7. PubMed ID: 8037186
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases.
Sase T; Wada H; Kamikura Y; Kaneko T; Abe Y; Nishioka J; Nobori T; Shiku H
Thromb Haemost; 2004 Jul; 92(1):132-9. PubMed ID: 15213854
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
[TBL] [Abstract][Full Text] [Related]
9. Microparticle-associated tissue factor activity in dogs with disseminated intravascular coagulation.
Kobayashi K; Baba K; Igase M; Miyama TS; Kambayashi S; Okuda M
J Vet Med Sci; 2020 Jan; 82(1):56-60. PubMed ID: 31787663
[TBL] [Abstract][Full Text] [Related]
10. Elevated tissue factor levels in leukemic cell homogenate.
Nakasaki T; Wada H; Watanabe R; Mori Y; Gabazza EC; Kageyama S; Nishikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jan; 6(1):14-7. PubMed ID: 10726043
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients.
Gando S; Nanzaki S; Morimoto Y; Ishitani T; Kemmotsu O
Crit Care Med; 2001 Feb; 29(2):262-6. PubMed ID: 11246303
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation.
Matsumoto H; Yamakawa K; Ogura H; Koh T; Matsumoto N; Shimazu T
Shock; 2015 May; 43(5):443-9. PubMed ID: 25608138
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.
Okugawa Y; Wada H; Noda T; Sakakura M; Nakasaki T; Watanabe R; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Nobori T; Shiku H
Am J Hematol; 2000 Nov; 65(3):210-4. PubMed ID: 11074537
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
16. Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Nakasaki T; Hiyoyama K; Mori Y; Nishikawa M; Deguchi H; Deguchi K; Gabazza EC; Shiku H
Am J Hematol; 1999 Feb; 60(2):94-8. PubMed ID: 9929099
[TBL] [Abstract][Full Text] [Related]
17. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis.
Gando S; Nanzaki S; Morimoto Y; Kobayashi S; Kemmotsu O
J Trauma; 1999 Oct; 47(4):719-23. PubMed ID: 10528607
[TBL] [Abstract][Full Text] [Related]
18. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
19. The tissue factor pathway in disseminated intravascular coagulation.
Østerud B; Bjørklid E
Semin Thromb Hemost; 2001 Dec; 27(6):605-17. PubMed ID: 11740684
[TBL] [Abstract][Full Text] [Related]
20. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity.
Warr TA; Rao LV; Rapaport SI
Blood; 1990 Apr; 75(7):1481-9. PubMed ID: 2317559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
